Charles River Laboratories
CRL
$301.93+0.97%
End of day · as of Oct 14, 2026, 8:00 PM ET
Mkt cap
$7.78B
EV/Sales
2.42
P/E ratio
N/A
FY2025 Revenue
$4.02B
EPS (TTM)
$-4.80
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-3.59%
Beta
1.48
Div yield
N/A
Sector
Healthcare
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. Revenue was down 0.9% from 2024-12-28 to 2025-12-27. CRL currently screens at market cap $7.78B.
Use this CRL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CRL income, balance, and cash tables.
Charles River Laboratories (CRL) is a diagnostics & research company in the Healthcare sector.
Latest cached Charles River Laboratories (CRL) revenue for Dec 27, 2025 was $4.02B. Net income was -$144.3M. Statements: https://lician.com/financials/crl
Charles River Laboratories (CRL) market capitalization is $7.78B on the latest cached snapshot.
Charles River Laboratories (CRL) cached previous close $299.02; day range $297.53 – $302.00; volume 936,243. Session quote: https://lician.com/quote/crl
Charles River Laboratories (CRL) latest cached earnings event is "CRL earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CRL filing is 8-K · Sep 24, 2026. Filings: https://lician.com/sec/crl